Europe Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

Name: Europe Kidney Disease Market
SKU: Pharmaceuticals
Rating: 4.9 (13 reviews)

Market Introduction

Kidney disease is also known as renal disease. It is caused due to the malfunctioning of the kidney. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others. For the treatment and diagnosis of these types of diseases, different global and regional players are offering various products and services.

Get more information on this report :

Market Overview and Dynamics

TheEuropekidney disease market is expected to reach US$ 37,311.1 million in 2027 from US$ 23,121.5million in 2019. The market is estimated to grow with a CAGR of 6.2% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as increasing incidences of chronic kidney diseases and growth in government expenditure in the healthcare sector. However, the market is expected experiencing slow growth during the forecast period owing to lack of awareness of kidney diseases.

Key Market Segments

Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.

Major Sources and Companies Listed

Some of the major primary and secondary sources forkidney disease market included in the report are European Kidney Health Alliance (EKHA), Kidney Care UK, National Health Examination Survey (Italy), and others.

Reasons to buy the report

To understand the Europekidney disease market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for kidney disease market
Efficiently plan M&A and partnership deals in Europekidney disease market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment formKidney disease market
Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region

EUROPEKIDNEY DISEASE MARKET SEGMENTATION

By Product

· Diagnosis

o Blood Tests

o Urine Tests

o Imaging Tests

o Others

· Treatment

o Dialysis

o Others

o Drug Class

§ ACE Inhibitors

§ Angiotensin-II Receptor Blockers

§ Diuretics

§ Others

By End User

· Hospitals

· Diagnostic Laboratories

· Others

By Country

· Europe

o Germany

o UK

o France

o Spain

o Italy

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Kidney Disease Market – By Product

1.3.2 Kidney Disease Market – By End User

1.3.3 EuropeKidney disease – By Country

2. EuropeKidney Disease – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. EuropeKidney Disease – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Kidney Disease Market- Europe PEST Analysis

4.3 Expert Opinion

5. EuropeKidney Disease - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidences of Kidney Diseases

5.1.2 Growth in Government Expenditure in the Healthcare Sector

5.2 Market Restraints

5.2.1 Lack of Awareness of Kidney Diseases

5.3 Market Opportunities

5.3.1 The rise in the Private Insurance Sector

5.4 Future Trends

5.4.1 Development in the Healthcare Infrastructure

5.5 Impact Analysis

6. Kidney Disease Market – Europe Analysis

6.1 EuropeKidney Disease Revenue Forecasts and Analysis

7. EuropeKidney Disease Analysis and Forecasts To 2027 – ByProduct

7.1 Overview

7.2 Kidney Disease Market Revenue Share, by Product (2019 and 2027)

7.3 Diagnosis

7.3.1 Overview

7.3.2 Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3 Blood Tests

7.3.3.1 Overview

7.3.3.2 Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)

7.3.4 Urine Tests

7.3.4.1 Overview

7.3.4.2 Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5 Imaging Tests

7.3.5.1 Overview

7.3.5.2 Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6 Others

7.3.6.1 Overview

7.3.6.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Treatment

7.4.1 Overview

7.4.2 Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3 Drug Class

7.4.3.1 Overview

7.4.3.2 Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.1 ACE Inhibitors

7.4.3.2.1.1 Overview

7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.2 Angiotensin-II Receptor Blockers

7.4.3.2.2.1 Overview

7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.3 Diuretics

7.4.3.2.3.1 Overview

7.4.3.2.3.2 Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.4 Others

7.4.3.2.4.1 Overview

7.4.3.2.4.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.4 Dialysis

7.4.4.1 Overview

7.4.4.2 Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.5 Others

7.4.5.1 Overview

7.4.5.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8. EuropeKidney disease Analysis – By End-User

8.1 Overview

8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Diagnostic Laboratories

8.4.1 Overview

8.4.2 Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

9. Kidney Disease Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1 Europe: Kidney Disease Market

9.1.1 Overview

9.1.2 Europe: Kidney Disease Market, - Revenue and Forecast to 2027 (USD Million)

9.1.3 Europe: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.1 Europe: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.3.2 Europe: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.1 Europe: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.4 Europe: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5 Europe: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.1.6 Germany: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1 Germany: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2 Germany: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.1 Germany: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2 Germany: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2.1 Germany: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.6.3 Germany: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.7 UK: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1 UK: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2 UK: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1 UK: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2 UK: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2.1 UK: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.7.3 UK: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8 France: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1 France: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2 France: Kidney Disease Market, by Product– Revenue and Forecast to 2027 (USD Million)

9.1.8.2.1 France: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2 France: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2.1 France: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.8.3 France: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.9 Italy: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1 Italy: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2 Italy: Kidney Disease Market, by Product– Revenue and Forecast to 2027 (USD Million)

9.1.9.2.1 Italy: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.9.2.2 Italy: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.9.2.2.1 Italy: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.9.3 Italy: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.10 Spain: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1 Spain: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2 Spain: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.10.2.1 Spain: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.10.2.2 Spain: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.10.2.2.1 Spain: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.10.3 Spain: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

10. Impact Of COVID-19 Pandemic on Europe Kidney disease

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. COMPANY PROFILES

11.1 Abbott

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 F. Hoffmann-La Roche Ltd.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Teva Pharmaceutical Industries Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 GlaxoSmithKline plc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

Source: Press Release, Newsletters, and Company Annual Report

12. Appendix

12.1 About the Insight Partners

12.2 Glossary of terms

LIST OF TABLES

Table 1. Europe: Kidney Disease Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 2. Europe: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 3. Europe: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 4. Europe: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5. Europe: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6. Germany: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7. Germany: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 8. Germany: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 9. Germany: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10. Germany: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11. UK: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 12. UK: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 13. UK: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14. UK: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15. UK: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16. France: Kidney Disease Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 17. France: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 18. France: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 19. France: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 20. France: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21. Italy: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 22. Italy: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 23. Italy: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 24. Italy: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 25. Italy: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 26. Spain: Kidney Disease Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 27. Spain: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 28. Spain: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 29. Spain: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 30. Spain: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31. Glossary of Terms,Kidney disease

LIST OF FIGURES

Figure 1. Kidney Disease Segmentation

Figure 2. EuropeKidney Disease Overview

Figure 3. Diagnosis Segment Held Largest Share of Product inKidney Disease Market

Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Kidney Disease Market - Europe PEST Analysis

Figure 6. Kidney Disease Market Impact Analysis of Driver and Restraints

Figure 7. EuropeKidney Disease – Revenue Forecasts and Analysis – 2019- 2027

Figure 8. Kidney Disease Market Revenue Share, by Product (2019 and 2027)

Figure 9. Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10. Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11. Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12. Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14. Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15. Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16. ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17. Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18. Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Kidney Disease Market Revenue Share, by End User (2019 and 2027)

Figure 23. Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24. Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25. Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Europe: Kidney Disease Market , by Key Country – Revenue (2019) (USD Million)

Figure 27. Europe: Kidney Disease Market, Revenue and Forecast to 2027 (USD Million)

Figure 28. Europe: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 29. Germany: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. UK: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 31. France: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Italy: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. Spain: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. Impact of COVID-19 Pandemic in Europeon Country Markets

The List of Companies - Europe Kidney Disease Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europekidney disease market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in theEurope kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Europe Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample